Overview of Dr. Forlenza
Dr. Christopher Forlenza is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from New York University Grossman School of Medicine and has been in practice 9 years. He is one of 92 doctors at Memorial Sloan Kettering Cancer Center and one of 132 doctors at New York-Presbyterian Hospital who specialize in Pediatric Hematology & Oncology. He has more than 10 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
New York University School of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2011 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma Start of enrollment: 2015 Mar 19
- An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Start of enrollment: 2019 Dec 27
Publications & Presentations
PubMed
- 1 citationsRadiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.Raymond B Mailhot Vega, Paul D Harker-Murray, Christopher J Forlenza, Peter Cole, Kara M Kelly, Sarah A Milgrom, Rahul R Parikh, David C Hodgson, Sharon M Castellino, ...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Oct 1
- 1 citationsBrentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.Christopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J Deyell, Jamie E Flerlage, Anna K Franklin, Jennifer ...> ;Blood Advances. 2023 Jul 11
- 1 citationsPrimary Mediastinal B-Cell Lymphoma in Children and Young Adults.Christopher J Forlenza, Amy Chadburn, Lisa Giulino-Roth> ;Journal of the National Comprehensive Cancer Network. 2023 Mar 1
- Join now to see all
Journal Articles
- KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.Forlenza CJ, Boudreau JE, Zheng J, Le Luduec JB, Chamberlain E, Heller G, Cheung NK, Hsu KC, Jounal of Clinical Oncology, 7/20/2016
Grant Support
- St. Baldrick's Fellow GrantSt. Baldrick's Foundation2014–2017
Professional Memberships
- Children's Oncology GroupMember
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
